AngioDynamics, Inc. (ANGO) vs MiMedx Group, Inc. (MDXG)
A side-by-side comparison of AngioDynamics, Inc. and MiMedx Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANGO
AngioDynamics, Inc.
$14.76HealthcareDelayed quote: Oct 6, 2026, 11:00 AM EDT
MDXG
MiMedx Group, Inc.
$4.57HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Total return — ANGO vs MDXG
growth of $100 · dividends reinvested · last 10yANGO -11.4% (-1.2%/yr)MDXG -48.5% (-6.4%/yr)ANGO compounded faster over this window
ANGO MDXG
ANGO vs MDXG: by the numbers
- •MDXG is the larger company ($665M vs $610M market cap).
- •MDXG is profitable (1.76% net margin) while ANGO runs a net loss (-11.48%).
- •MDXG grew revenue faster over the past five years (6.36% vs 1.93% CAGR).
Metrics side by side
Valuation
| Metric | ANGO | MDXG |
|---|---|---|
| P/E ratio | N/A | 114.13 |
| P/S ratio | 1.91 | 1.87 |
| P/B ratio | 3.57 | 3.08 |
| EV / EBITDA | N/A | 26.02 |
| FCF yield | 0.08% | 6.10% |
Profitability
| Metric | ANGO | MDXG |
|---|---|---|
| Gross margin | 54.62% | 78.85% |
| Operating margin | -12.47% | 15.26% |
| Net margin | -11.48% | 1.76% |
| ROE | -21.51% | 2.89% |
| ROIC | -20.75% | 1.97% |
Growth (annualized)
| Metric | ANGO | MDXG |
|---|---|---|
| Revenue CAGR (5Y) | 1.93% | 6.36% |
| FCF CAGR (5Y) | -51.49% | N/A |
| Total return CAGR (5Y) | -10.80% | -4.94% |
Frequently asked
- Which has grown faster, ANGO or MDXG?
- Over the past five years, MDXG grew revenue faster — ANGO at a 1.93% CAGR versus MDXG at 6.36%.
- Is ANGO or MDXG more profitable?
- MDXG runs the higher net margin — ANGO at -11.48% versus MDXG at 1.76%.
- How have ANGO and MDXG total returns compared?
- Over the past 10 years, ANGO delivered -0.58% and MDXG delivered -6.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MiMedx P/E ratioAngioDynamics ROEMiMedx ROEAngioDynamics operating marginMiMedx operating marginAngioDynamics revenue growthMiMedx revenue growthAngioDynamics free cash flowMiMedx free cash flow
AngioDynamics & MiMedx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.